Details of the Drug
General Information of Drug (ID: DM18E9D)
| Drug Name |
(1R,2R)-1,2-diphenylethane-1,2-diamine
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
35132-20-8; (1R,2R)-(+)-1,2-Diphenylethylenediamine; (1R,2R)-rel-1,2-Diphenylethane-1,2-diamine; (1R,2R)-1,2-Diphenylethylenediamine; 16635-95-3; (+)-1,2-diphenylethylenediamine; MFCD00082769; (+)-STILBENEDIAMINE; (R,R)-DPEN; (r,r)-(+)-1,2-diphenylethylenediamine; CHEMBL381340; (1r,2r)-1,2-diphenyl-ethane-1,2-diamine; 1,2-Ethanediamine, 1,2-diphenyl-, (1R,2R)-; (1R,2R)-(+)-1,2-Diphenyl-1,2-ethane diam
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 212.29 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.4 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


